Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Mod lisation PK PD). Showing records 1 – 30 of 872 total matches.

[1] [2] [3] [4] [5] … [30]

Search Limiters

Last 2 Years | English Only

Department

Degrees

Levels

Languages

Country

▼ Search Limiters


University of Houston

1. He, Yu. Development of Combination Therapies of Pazopanib Through a PK/PD Approach.

Degree: Pharmacological and Pharmaceutical Sciences, Department of, 2018, University of Houston

 Objective: The increased efflux of tyrosine kinase inhibitors (TKIs) by multidrug resistance-related ATP-binding cassette (ABC) transporters represents an important mechanism of TKIs resistance. Interestingly, many… (more)

Subjects/Keywords: tyrosine kinase inhibitors; multidrug resistance; P-gp; combination therapy; PK/PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

He, Y. (2018). Development of Combination Therapies of Pazopanib Through a PK/PD Approach. (Thesis). University of Houston. Retrieved from http://hdl.handle.net/10657/3404

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

He, Yu. “Development of Combination Therapies of Pazopanib Through a PK/PD Approach.” 2018. Thesis, University of Houston. Accessed August 20, 2019. http://hdl.handle.net/10657/3404.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

He, Yu. “Development of Combination Therapies of Pazopanib Through a PK/PD Approach.” 2018. Web. 20 Aug 2019.

Vancouver:

He Y. Development of Combination Therapies of Pazopanib Through a PK/PD Approach. [Internet] [Thesis]. University of Houston; 2018. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10657/3404.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

He Y. Development of Combination Therapies of Pazopanib Through a PK/PD Approach. [Thesis]. University of Houston; 2018. Available from: http://hdl.handle.net/10657/3404

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Oxford

2. Hutton-Smith, Laurence. Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD.

Degree: PhD, 2018, University of Oxford

 Wet age related macular degeneration (wet AMD) is a highly debilitating retinal disease, the third leading cause of blindness in the world and one the… (more)

Subjects/Keywords: 510; PK/PD; wet amd; IVT injection; mathematical modelling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hutton-Smith, L. (2018). Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871

Chicago Manual of Style (16th Edition):

Hutton-Smith, Laurence. “Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD.” 2018. Doctoral Dissertation, University of Oxford. Accessed August 20, 2019. http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871.

MLA Handbook (7th Edition):

Hutton-Smith, Laurence. “Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD.” 2018. Web. 20 Aug 2019.

Vancouver:

Hutton-Smith L. Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD. [Internet] [Doctoral dissertation]. University of Oxford; 2018. [cited 2019 Aug 20]. Available from: http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871.

Council of Science Editors:

Hutton-Smith L. Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD. [Doctoral Dissertation]. University of Oxford; 2018. Available from: http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871


University of Minnesota

3. Basu, Cynthia. Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials.

Degree: PhD, Biostatistics, 2017, University of Minnesota

 A rare disease is defined by the Rare Diseases Act of 2002 as a disease that currently affects fewer than 200,000 patients in the USA.… (more)

Subjects/Keywords: Bayesian Hierarchical Models; Clinical Trials; Data Extrapolation; PK/PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Basu, C. (2017). Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/191398

Chicago Manual of Style (16th Edition):

Basu, Cynthia. “Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials.” 2017. Doctoral Dissertation, University of Minnesota. Accessed August 20, 2019. http://hdl.handle.net/11299/191398.

MLA Handbook (7th Edition):

Basu, Cynthia. “Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials.” 2017. Web. 20 Aug 2019.

Vancouver:

Basu C. Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials. [Internet] [Doctoral dissertation]. University of Minnesota; 2017. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/11299/191398.

Council of Science Editors:

Basu C. Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials. [Doctoral Dissertation]. University of Minnesota; 2017. Available from: http://hdl.handle.net/11299/191398


Universidad Nacional de La Plata

4. Meneses, María Laura. Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos.

Degree: 2013, Universidad Nacional de La Plata

En la actualidad, la CIM asume un papel fundamental en el cálculo de los parámetros farmacocinéticos/farmacodinámicos, T>CIM; AUC/CIM y Cmax/CIM, considerados como predictores de la… (more)

Subjects/Keywords: Ciencias Veterinarias; Cefalexina; Farmacocinética; Ciprofloxacino; Farmacia; farmacodinamia; antimicrobianos; PK/PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meneses, M. L. (2013). Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos. (Thesis). Universidad Nacional de La Plata. Retrieved from http://hdl.handle.net/10915/45025

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Meneses, María Laura. “Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos.” 2013. Thesis, Universidad Nacional de La Plata. Accessed August 20, 2019. http://hdl.handle.net/10915/45025.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Meneses, María Laura. “Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos.” 2013. Web. 20 Aug 2019.

Vancouver:

Meneses ML. Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos. [Internet] [Thesis]. Universidad Nacional de La Plata; 2013. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10915/45025.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Meneses ML. Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos. [Thesis]. Universidad Nacional de La Plata; 2013. Available from: http://hdl.handle.net/10915/45025

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

5. Giraud, Cristina Sanches. Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva.

Degree: PhD, Produção e Controle Farmacêuticos, 2011, University of São Paulo

 Introdução: A sepse é a maior causa de morbidade e mortalidade em pacientes queimados, uma vez que profundas alterações ocorrem na farmacocinética de agentes antimicrobianos… (more)

Subjects/Keywords: Burns; Control of infections; Controle das infecções; Dose adjusted therapy; Drug plasma monitoring; Modelagem farmacocinética; Monitoramento plasmático; Pharmacokinetics; PK-PD; PK-PD modeling; Queimados; Sepse; Sepsis; Terapia dose ajustada

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Giraud, C. S. (2011). Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;

Chicago Manual of Style (16th Edition):

Giraud, Cristina Sanches. “Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva.” 2011. Doctoral Dissertation, University of São Paulo. Accessed August 20, 2019. http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;.

MLA Handbook (7th Edition):

Giraud, Cristina Sanches. “Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva.” 2011. Web. 20 Aug 2019.

Vancouver:

Giraud CS. Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva. [Internet] [Doctoral dissertation]. University of São Paulo; 2011. [cited 2019 Aug 20]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;.

Council of Science Editors:

Giraud CS. Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva. [Doctoral Dissertation]. University of São Paulo; 2011. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;

6. Djabarouti, Sarah. Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases.

Degree: Docteur es, Sciences, technologie, santé. Pharmacologie, 2009, Université de Bordeaux Segalen

L’acide mycophénolique (MPA) est un immunosuppresseur très prometteur dans le traitement des maladies auto-immunes (MAI) telles que le lupus érythémateux disséminé (LED) et les vascularites… (more)

Subjects/Keywords: Acide mycophénolique; Corrélations PK/PD; Lupus érythémateux disséminé; Vascularites à ANCA; Mycophenolic acid; PK/PD relationships; Systemic lupus erythematosus; ANCA-associated vasculitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Djabarouti, S. (2009). Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases. (Doctoral Dissertation). Université de Bordeaux Segalen. Retrieved from http://www.theses.fr/2009BOR21699

Chicago Manual of Style (16th Edition):

Djabarouti, Sarah. “Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases.” 2009. Doctoral Dissertation, Université de Bordeaux Segalen. Accessed August 20, 2019. http://www.theses.fr/2009BOR21699.

MLA Handbook (7th Edition):

Djabarouti, Sarah. “Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases.” 2009. Web. 20 Aug 2019.

Vancouver:

Djabarouti S. Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases. [Internet] [Doctoral dissertation]. Université de Bordeaux Segalen; 2009. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2009BOR21699.

Council of Science Editors:

Djabarouti S. Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases. [Doctoral Dissertation]. Université de Bordeaux Segalen; 2009. Available from: http://www.theses.fr/2009BOR21699


INP Toulouse

7. Pastor, Mélanie. Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients.

Degree: Docteur es, Pathologie, Toxicologie, Génétique et Nutrition, 2013, INP Toulouse

Une des stratégies pour limiter les neutropénies induites par la chimiothérapie est l’utilisation de granulocyte-colony stimulating factor (G-CSF). Nous avons développé, par une approche de… (more)

Subjects/Keywords: Myélotoxicité; Neutropénie; Chimiothérapie; Granulocyte colony-stimulating factor (G-CSF); Modélisation pharmacocinétique/pharmacodynamique (PK/PD); Carboplatine; Myelotoxicity; Neutropenia; Chemotherapy; Granulocyte colony-stimulating factor (G-CSF); Pharmacokinetic/pharmacodynamic (PK/PD) modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pastor, M. (2013). Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients. (Doctoral Dissertation). INP Toulouse. Retrieved from http://www.theses.fr/2013INPT0061

Chicago Manual of Style (16th Edition):

Pastor, Mélanie. “Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients.” 2013. Doctoral Dissertation, INP Toulouse. Accessed August 20, 2019. http://www.theses.fr/2013INPT0061.

MLA Handbook (7th Edition):

Pastor, Mélanie. “Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients.” 2013. Web. 20 Aug 2019.

Vancouver:

Pastor M. Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients. [Internet] [Doctoral dissertation]. INP Toulouse; 2013. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2013INPT0061.

Council of Science Editors:

Pastor M. Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients. [Doctoral Dissertation]. INP Toulouse; 2013. Available from: http://www.theses.fr/2013INPT0061


Temple University

8. Sharma, Jyoti. Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model.

Degree: PhD, 2013, Temple University

Pharmaceutical Sciences

Glioblastomas are highly vascular brain tumors that are characterized as heterogeneous, comprised of an anatomically and functionally irregular blood brain barrier (BBB) that… (more)

Subjects/Keywords: Pharmaceutical sciences;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sharma, J. (2013). Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,228240

Chicago Manual of Style (16th Edition):

Sharma, Jyoti. “Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model.” 2013. Doctoral Dissertation, Temple University. Accessed August 20, 2019. http://digital.library.temple.edu/u?/p245801coll10,228240.

MLA Handbook (7th Edition):

Sharma, Jyoti. “Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model.” 2013. Web. 20 Aug 2019.

Vancouver:

Sharma J. Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model. [Internet] [Doctoral dissertation]. Temple University; 2013. [cited 2019 Aug 20]. Available from: http://digital.library.temple.edu/u?/p245801coll10,228240.

Council of Science Editors:

Sharma J. Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model. [Doctoral Dissertation]. Temple University; 2013. Available from: http://digital.library.temple.edu/u?/p245801coll10,228240

9. 張, 仁美. 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients.

Degree: 博士(医学), 2014, Niigata University / 新潟大学

学位の種類: 博士(医学). 報告番号: 甲第3943号. 学位記番号: 新大院博(医)甲第610号.学位授与年月日: 平成26年9月22日

これまで使用されてきたLevofloxacin (LVFX) 低用量(100mg)製剤に変わって、2009年に発売された500mg、250mg製剤の日本人透析患者における血中濃度、安全性を検討した報告は少ないため、感染症治療のためにLVFXを使用した透析患者に対し、透析前血中トラフ濃度の測定を行い、血液透析患者における血中濃度を確認した。今回9症例を登録し解析した。全例LVFXで感染症の症状は軽快していた。全症例の平均血中トラフ値は3.46±1.42μg/mlであった。500mg単回投与で投与後二日目の透析直前の平均が4.18±1.35μg/mlで、透析間隔の関係により72時間時点で採血した症例では2.93であった。また、複数回投与症例においても最終投与後48時間での血中濃度トラフ値は平均2.17±0.72μg/mlと複数回投与でも薬剤の蓄積傾向はなかった。一方で体重と血中濃度のトラフ値には単回投与群で明確な相関がみられた。LVFX500mg錠発売後、多くの透析患者での使用実績があり透析患者においても重篤な有害事象の報告は少なく安全に使用できる薬剤であるが、透析患者では高齢者、低体重患者も多くPK-PD上の至適用量として減量が可能な症例の有無等さらなるデータ蓄積が望まれる。

Subjects/Keywords: LVFX; 血液透析; 血中トラフ濃度; PK-PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

張, . (2014). 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients. (Thesis). Niigata University / 新潟大学. Retrieved from http://hdl.handle.net/10191/30971

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

張, 仁美. “日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients.” 2014. Thesis, Niigata University / 新潟大学. Accessed August 20, 2019. http://hdl.handle.net/10191/30971.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

張, 仁美. “日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients.” 2014. Web. 20 Aug 2019.

Vancouver:

張 . 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients. [Internet] [Thesis]. Niigata University / 新潟大学; 2014. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10191/30971.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

張 . 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients. [Thesis]. Niigata University / 新潟大学; 2014. Available from: http://hdl.handle.net/10191/30971

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Fors, John. Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence.

Degree: Bioscience, 2012, University of Skövde

  Antiretroviral drugs have revolutionized HIV care and enabled better management of the infection thus allowing patients survive for many years. One proposed approach to… (more)

Subjects/Keywords: HIV; antiretroviral; adherence; reduced dose; viral resistance; PK/PD; efavirenz; rifampin; CYP2B6

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fors, J. (2012). Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence. (Thesis). University of Skövde. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fors, John. “Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence.” 2012. Thesis, University of Skövde. Accessed August 20, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fors, John. “Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence.” 2012. Web. 20 Aug 2019.

Vancouver:

Fors J. Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence. [Internet] [Thesis]. University of Skövde; 2012. [cited 2019 Aug 20]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fors J. Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence. [Thesis]. University of Skövde; 2012. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Rezai Gharahbolagh, Keyvan. Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib.

Degree: Docteur es, Pharmacologie, 2012, Université Paris Descartes – Paris V

La mise en évidence de la variabilité pharmacocinétique et/ou pharmacodynamique permet l’optimisation de l’utilisation des cytotoxiques. L’association des thérapies ciblées à la chimiothérapie conventionnelle peut… (more)

Subjects/Keywords: Pharmacocinétique; Pharmacodynamie; Thérapie ciblée; Variabilités Interindividuelles; Modélisation; Pharmacokinetics; Pharmacodynamics; Targeted therapy; Interpatient Variabilities; PK-PD Modeling; 616.994 06

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rezai Gharahbolagh, K. (2012). Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib. (Doctoral Dissertation). Université Paris Descartes – Paris V. Retrieved from http://www.theses.fr/2012PA05P606

Chicago Manual of Style (16th Edition):

Rezai Gharahbolagh, Keyvan. “Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib.” 2012. Doctoral Dissertation, Université Paris Descartes – Paris V. Accessed August 20, 2019. http://www.theses.fr/2012PA05P606.

MLA Handbook (7th Edition):

Rezai Gharahbolagh, Keyvan. “Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib.” 2012. Web. 20 Aug 2019.

Vancouver:

Rezai Gharahbolagh K. Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib. [Internet] [Doctoral dissertation]. Université Paris Descartes – Paris V; 2012. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2012PA05P606.

Council of Science Editors:

Rezai Gharahbolagh K. Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib. [Doctoral Dissertation]. Université Paris Descartes – Paris V; 2012. Available from: http://www.theses.fr/2012PA05P606


Universidade do Rio Grande do Sul

12. Azeredo, Francine Johansson. Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol.

Degree: 2013, Universidade do Rio Grande do Sul

 Objetivos: O objetivo deste trabalho foi o estabelecimento de um modelo PK/PD capaz de descrever o efeito fungistático de fluconazol (FCZ) contra diferentes espécies de… (more)

Subjects/Keywords: Fluconazole; Modelagem farmacocinética-farmacodinâmica; Renal microdialysis; Fluconazol; Antifúngicos; Candida spp.; Microdialise; In vitro model infection; PK/PD modeling; Candida

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Azeredo, F. J. (2013). Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/72917

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Azeredo, Francine Johansson. “Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol.” 2013. Thesis, Universidade do Rio Grande do Sul. Accessed August 20, 2019. http://hdl.handle.net/10183/72917.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Azeredo, Francine Johansson. “Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol.” 2013. Web. 20 Aug 2019.

Vancouver:

Azeredo FJ. Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2013. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10183/72917.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Azeredo FJ. Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol. [Thesis]. Universidade do Rio Grande do Sul; 2013. Available from: http://hdl.handle.net/10183/72917

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade do Rio Grande do Sul

13. Alves, Izabel Almeida. Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans.

Degree: 2017, Universidade do Rio Grande do Sul

 O objetivo desta tese foi desenvolver um modelo farmacocinético-farmacodinâmico (PK-PD) aplicável a avaliação de esquemas posológicos de antifúngicos sistêmicos no tratamento de infecções cerebrais associadas… (more)

Subjects/Keywords: Cryptococcus neoformans; Cryptococcus neoformans; Modelagem farmacocinética-farmacodinâmica; Monte Carlo simulation; Antifúngicos; PK-PD modeling; Brain penetration; Microdialysis; Voriconazole; Fluconazole

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alves, I. A. (2017). Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/170662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alves, Izabel Almeida. “Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans.” 2017. Thesis, Universidade do Rio Grande do Sul. Accessed August 20, 2019. http://hdl.handle.net/10183/170662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alves, Izabel Almeida. “Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans.” 2017. Web. 20 Aug 2019.

Vancouver:

Alves IA. Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2017. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10183/170662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alves IA. Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans. [Thesis]. Universidade do Rio Grande do Sul; 2017. Available from: http://hdl.handle.net/10183/170662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Houston

14. Teng, Yang 1982-. Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation.

Degree: Pharmacological and Pharmaceutical Sciences, Department of, University of Houston

 Acute Spinal Cord injury (SCI) is a complex disorder involving a sudden traumatic insult to the cord resulting in deficits to ambulatory, sensory and autonomic… (more)

Subjects/Keywords: Riluzole; Pharmacokinetics; Spinal Cord Injury; NONMEM; PK/PD Correlation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Teng, Y. 1. (n.d.). Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation. (Thesis). University of Houston. Retrieved from http://hdl.handle.net/10657/2974

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Teng, Yang 1982-. “Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation.” Thesis, University of Houston. Accessed August 20, 2019. http://hdl.handle.net/10657/2974.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Teng, Yang 1982-. “Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation.” Web. 20 Aug 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Teng Y1. Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation. [Internet] [Thesis]. University of Houston; [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10657/2974.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Teng Y1. Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation. [Thesis]. University of Houston; Available from: http://hdl.handle.net/10657/2974

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


UCLA

15. Shi, Yu. Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest.

Degree: Biostatistics, 2019, UCLA

 There are many challenging optimization problems in the health sciences. Problems in health sciences are increasingly complex, and frequently the most advanced optimization techniques are… (more)

Subjects/Keywords: Biostatistics; Medical imaging; Interstitial lung disease; Longitudinal optimal designs; Medical imaging; Non-linear mixed effects models; PK/PD studies; Texture features

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shi, Y. (2019). Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/0k99z04n

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Shi, Yu. “Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest.” 2019. Thesis, UCLA. Accessed August 20, 2019. http://www.escholarship.org/uc/item/0k99z04n.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Shi, Yu. “Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest.” 2019. Web. 20 Aug 2019.

Vancouver:

Shi Y. Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest. [Internet] [Thesis]. UCLA; 2019. [cited 2019 Aug 20]. Available from: http://www.escholarship.org/uc/item/0k99z04n.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Shi Y. Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest. [Thesis]. UCLA; 2019. Available from: http://www.escholarship.org/uc/item/0k99z04n

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Iowa

16. Bi, Youwei. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects.

Degree: PhD, Pharmaceutical Sciences and Experimental Therapeutics, 2016, University of Iowa

  Depot intramuscularly administered testosterone cypionate (TC) is indicated for treatment of hypogonadism in males. However, illegal use of TC and other anabolic steroids in… (more)

Subjects/Keywords: Abuse of steroids; Luteinizing hormone; Population pharmacokinetic/pharmacodynamic (PK/PD) modeling; Spermatogenesis; Testosterone cypionate; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bi, Y. (2016). Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/5716

Chicago Manual of Style (16th Edition):

Bi, Youwei. “Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects.” 2016. Doctoral Dissertation, University of Iowa. Accessed August 20, 2019. https://ir.uiowa.edu/etd/5716.

MLA Handbook (7th Edition):

Bi, Youwei. “Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects.” 2016. Web. 20 Aug 2019.

Vancouver:

Bi Y. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects. [Internet] [Doctoral dissertation]. University of Iowa; 2016. [cited 2019 Aug 20]. Available from: https://ir.uiowa.edu/etd/5716.

Council of Science Editors:

Bi Y. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects. [Doctoral Dissertation]. University of Iowa; 2016. Available from: https://ir.uiowa.edu/etd/5716


University of Iowa

17. Xie, Lanyi. Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics.

Degree: PhD, Pharmacy, 2011, University of Iowa

  The development of type 2 diabetes over time involves defects in insulin action and insulin secretion. Defects in insulin action alone can be compensated… (more)

Subjects/Keywords: Beta-cell; First-phase insulin; Glucose tolerance; Insulin modeling; Insulin secretion; Population PK/PD; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Xie, L. (2011). Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/2791

Chicago Manual of Style (16th Edition):

Xie, Lanyi. “Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics.” 2011. Doctoral Dissertation, University of Iowa. Accessed August 20, 2019. https://ir.uiowa.edu/etd/2791.

MLA Handbook (7th Edition):

Xie, Lanyi. “Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics.” 2011. Web. 20 Aug 2019.

Vancouver:

Xie L. Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics. [Internet] [Doctoral dissertation]. University of Iowa; 2011. [cited 2019 Aug 20]. Available from: https://ir.uiowa.edu/etd/2791.

Council of Science Editors:

Xie L. Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics. [Doctoral Dissertation]. University of Iowa; 2011. Available from: https://ir.uiowa.edu/etd/2791

18. Santos, Verônica Jorge. Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio.

Degree: PhD, Produção e Controle Farmacêuticos, 2008, University of São Paulo

Introdução: A administração de morfina através de bomba de infusão controlada pelo paciente (ACP) no tratamento da dor pós-cirurgica e traumática tem-se mostrado promissora e… (more)

Subjects/Keywords: Área sob a curva; Area under the curve; Fármaco; Intensidade da dor pós-operatória; LC-MS/MS (ESI+); LC-MS/MS (ESI+); Modelo PK-PD; Morfina ACP; Morphine PCA; Pharmaco; PK-PD modeling; Postoperative pain

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santos, V. J. (2008). Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;

Chicago Manual of Style (16th Edition):

Santos, Verônica Jorge. “Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio.” 2008. Doctoral Dissertation, University of São Paulo. Accessed August 20, 2019. http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;.

MLA Handbook (7th Edition):

Santos, Verônica Jorge. “Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio.” 2008. Web. 20 Aug 2019.

Vancouver:

Santos VJ. Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio. [Internet] [Doctoral dissertation]. University of São Paulo; 2008. [cited 2019 Aug 20]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;.

Council of Science Editors:

Santos VJ. Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio. [Doctoral Dissertation]. University of São Paulo; 2008. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;

19. Pierrillas, Philippe. Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data.

Degree: Docteur es, Pharmacométrie, 2016, Lyon

L’amélioration du développement du médicament est un véritable défi et ceci encore plus dans le domaine de l’oncologie dans lequel le besoin d’avoir de nouvelles… (more)

Subjects/Keywords: Approche translationnelle inter-espèces; Développement du médicament; Oncologie; Inhibiteur de bcl-2; Apoptose; Modèle PK-PD; Modèle PBPK; Interspecies translational approach; Drug development; Oncology; Bcl-2 inhibitor; Apoptosis; PK-PD model; PBPK model; 615

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pierrillas, P. (2016). Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2016LYSE1047

Chicago Manual of Style (16th Edition):

Pierrillas, Philippe. “Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data.” 2016. Doctoral Dissertation, Lyon. Accessed August 20, 2019. http://www.theses.fr/2016LYSE1047.

MLA Handbook (7th Edition):

Pierrillas, Philippe. “Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data.” 2016. Web. 20 Aug 2019.

Vancouver:

Pierrillas P. Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data. [Internet] [Doctoral dissertation]. Lyon; 2016. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2016LYSE1047.

Council of Science Editors:

Pierrillas P. Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data. [Doctoral Dissertation]. Lyon; 2016. Available from: http://www.theses.fr/2016LYSE1047

20. Bouchnita, Anass. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques.

Degree: Docteur es, Physiologie et biologie des organismes. Populations. Interactions, 2017, Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc)

Cette thèse est consacrée à la modélisation mathématique de la coagulation sanguine et de la formation de thrombus dans des conditions normales et pathologiques. La… (more)

Subjects/Keywords: Coagulation sanguine; Formation de caillots dans l'écoulement sanguin; Thrombose; Saignement; Modélisation mathématique; Simulation numérique; Modèles multi-échelles hybrides; Modélisation PK-PD des médicaments anticoagulants; Blood coagulation; Clot formation in blood flow; Thrombosis; Bleeding; Mathematical modelling; Numerical simulation; Hybrid multiscale models; PK-PD modelling of anticoagulant drugs; 570.15

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bouchnita, A. (2017). Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques. (Doctoral Dissertation). Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc). Retrieved from http://www.theses.fr/2017LYSE1300

Chicago Manual of Style (16th Edition):

Bouchnita, Anass. “Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques.” 2017. Doctoral Dissertation, Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc). Accessed August 20, 2019. http://www.theses.fr/2017LYSE1300.

MLA Handbook (7th Edition):

Bouchnita, Anass. “Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques.” 2017. Web. 20 Aug 2019.

Vancouver:

Bouchnita A. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques. [Internet] [Doctoral dissertation]. Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc); 2017. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2017LYSE1300.

Council of Science Editors:

Bouchnita A. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques. [Doctoral Dissertation]. Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc); 2017. Available from: http://www.theses.fr/2017LYSE1300

21. Brill, Margreke Jantine Eltje. Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery.

Degree: 2015, Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University

 Drug concentrations and effects may be different in morbidly obese patients (body mass index > 40 kg/m2). In addition, also such changes may be expected… (more)

Subjects/Keywords: Morbid Obesity; Cefazolin; Midazolam; Bariatric surgery; Microdialysis; PK-PD modeling; Morbid Obesity; Cefazolin; Midazolam; Bariatric surgery; Microdialysis; PK-PD modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Brill, M. J. E. (2015). Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery. (Doctoral Dissertation). Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/36511

Chicago Manual of Style (16th Edition):

Brill, Margreke Jantine Eltje. “Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery.” 2015. Doctoral Dissertation, Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University. Accessed August 20, 2019. http://hdl.handle.net/1887/36511.

MLA Handbook (7th Edition):

Brill, Margreke Jantine Eltje. “Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery.” 2015. Web. 20 Aug 2019.

Vancouver:

Brill MJE. Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery. [Internet] [Doctoral dissertation]. Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University; 2015. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/1887/36511.

Council of Science Editors:

Brill MJE. Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery. [Doctoral Dissertation]. Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University; 2015. Available from: http://hdl.handle.net/1887/36511

22. Ackaert, Oliver. Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application.

Degree: 2010, Faculty of Science, Leiden University

 Parkinson’s disease (PD) is an age-related neurodegenerative disorder. Pharmacotherapy is the first line symptomatic treatment of this neurological disease. Currently Levodopa (L-DOPA) is still considered… (more)

Subjects/Keywords: Dopamine agonists; Drug delivery; Parkinson's disease; Percutaneous; PK-PD modeling; Dopamine agonists; Drug delivery; Parkinson's disease; Percutaneous; PK-PD modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ackaert, O. (2010). Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application. (Doctoral Dissertation). Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/15336

Chicago Manual of Style (16th Edition):

Ackaert, Oliver. “Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application.” 2010. Doctoral Dissertation, Faculty of Science, Leiden University. Accessed August 20, 2019. http://hdl.handle.net/1887/15336.

MLA Handbook (7th Edition):

Ackaert, Oliver. “Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application.” 2010. Web. 20 Aug 2019.

Vancouver:

Ackaert O. Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application. [Internet] [Doctoral dissertation]. Faculty of Science, Leiden University; 2010. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/1887/15336.

Council of Science Editors:

Ackaert O. Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application. [Doctoral Dissertation]. Faculty of Science, Leiden University; 2010. Available from: http://hdl.handle.net/1887/15336

23. Noppers, Ingeborg Marieke. Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain.

Degree: 2011, Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University

 The balance between safety and efficacy is important in pharmacotherapy. When the indication of a registered drug shifts to another disease or a different patient… (more)

Subjects/Keywords: CRPS; Fibromyalgia; Ketamine; Norketamine; Pain; PK-PD; CRPS; Fibromyalgia; Ketamine; Norketamine; Pain; PK-PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Noppers, I. M. (2011). Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain. (Doctoral Dissertation). Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University. Retrieved from http://hdl.handle.net/1887/17811

Chicago Manual of Style (16th Edition):

Noppers, Ingeborg Marieke. “Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain.” 2011. Doctoral Dissertation, Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University. Accessed August 20, 2019. http://hdl.handle.net/1887/17811.

MLA Handbook (7th Edition):

Noppers, Ingeborg Marieke. “Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain.” 2011. Web. 20 Aug 2019.

Vancouver:

Noppers IM. Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain. [Internet] [Doctoral dissertation]. Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University; 2011. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/1887/17811.

Council of Science Editors:

Noppers IM. Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain. [Doctoral Dissertation]. Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University; 2011. Available from: http://hdl.handle.net/1887/17811

24. Chauzy, Alexia. Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam.

Degree: Docteur es, Pharmacie, 2018, Poitiers

L'augmentation des résistances aux antibiotiques ces dernières années et le faible nombre de nouveaux antibiotiques récemment approuvés ont suscité un intérêt considérable pour les associations… (more)

Subjects/Keywords: Aztréonam; Avibactam; Association β-Lactamine-Inhibiteur de β-Lactamases; Interaction; Microdialyse; Pharmacocinétique; Pharmacodynamique; Modèle PK/PD; Aztréonam; Avibactam; Association β-Lactamine-Inhibiteur de β-Lactamases; Interaction; Microdialyse; Pharmacocinétique; Pharmacodynamique; Modèle PK/PD; 615.792 2; 615.329

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chauzy, A. (2018). Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam. (Doctoral Dissertation). Poitiers. Retrieved from http://www.theses.fr/2018POIT1802

Chicago Manual of Style (16th Edition):

Chauzy, Alexia. “Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam.” 2018. Doctoral Dissertation, Poitiers. Accessed August 20, 2019. http://www.theses.fr/2018POIT1802.

MLA Handbook (7th Edition):

Chauzy, Alexia. “Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam.” 2018. Web. 20 Aug 2019.

Vancouver:

Chauzy A. Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam. [Internet] [Doctoral dissertation]. Poitiers; 2018. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2018POIT1802.

Council of Science Editors:

Chauzy A. Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam. [Doctoral Dissertation]. Poitiers; 2018. Available from: http://www.theses.fr/2018POIT1802

25. Maas, Hugo J. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs.

Degree: 2007, Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University

 The objective of the investigations described in this thesis was the development of novel PK-PD modelling for the characterisation and prediction of the effects of… (more)

Subjects/Keywords: Headache; Markov chains; Migraine; Naratripta; PK-PD modelling; Sumatriptan; Headache; Markov chains; Migraine; Naratripta; PK-PD modelling; Sumatriptan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maas, H. J. (2007). A Markov approach to characterising the PK-PD relationship of anti-migraine drugs. (Doctoral Dissertation). Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/12040

Chicago Manual of Style (16th Edition):

Maas, Hugo J. “A Markov approach to characterising the PK-PD relationship of anti-migraine drugs.” 2007. Doctoral Dissertation, Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University. Accessed August 20, 2019. http://hdl.handle.net/1887/12040.

MLA Handbook (7th Edition):

Maas, Hugo J. “A Markov approach to characterising the PK-PD relationship of anti-migraine drugs.” 2007. Web. 20 Aug 2019.

Vancouver:

Maas HJ. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs. [Internet] [Doctoral dissertation]. Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University; 2007. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/1887/12040.

Council of Science Editors:

Maas HJ. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs. [Doctoral Dissertation]. Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University; 2007. Available from: http://hdl.handle.net/1887/12040


Universidade do Rio Grande do Sul

26. Hurtado, Felipe Kellermann. Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite.

Degree: 2014, Universidade do Rio Grande do Sul

 Objetivo: O objetivo geral deste trabalho foi desenvolver um modelo farmacocinético/farmacodinâmico (PK/PD) para descrever o efeito bactericida in vitro das fluoroquinolonas levofloxacino (LEV) e moxifloxacino… (more)

Subjects/Keywords: Antimicrobials; Modelagem farmacocinética-farmacodinâmica; Prostatitis; Fluoroquinolonas; Levofloxacino; Fluoroquinolones; Levofloxacin; Moxifloxacino; Prostatite; Moxifloxacin; Microdialysis; Pharmacokinetics; PK/PD modeling; Escherichia coli; Time-kill curves

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hurtado, F. K. (2014). Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/99003

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hurtado, Felipe Kellermann. “Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite.” 2014. Thesis, Universidade do Rio Grande do Sul. Accessed August 20, 2019. http://hdl.handle.net/10183/99003.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hurtado, Felipe Kellermann. “Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite.” 2014. Web. 20 Aug 2019.

Vancouver:

Hurtado FK. Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2014. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10183/99003.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hurtado FK. Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite. [Thesis]. Universidade do Rio Grande do Sul; 2014. Available from: http://hdl.handle.net/10183/99003

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade do Rio Grande do Sul

27. Tasso, Leandro. Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino.

Degree: 2008, Universidade do Rio Grande do Sul

 Objetivo: O objetivo geral deste trabalho foi estabelecer modelo farmacocinéticofarmacodinâmico (modelo PK/PD) para descrever o perfil temporal do efeito bactericida do levofloxacino e do gatifloxacino… (more)

Subjects/Keywords: Modelagem farmacocinética-farmacodinâmica; Levofloxacin; Gatifloxacin; Fluoroquinolonas; Lung microdialysis; Gatifloxacino; PK/PD modeling; Levofloxacino; In vitro infection model; Microdialise; Modelo de infecção in vitro; Validação : Métodos de análise de fármacos

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tasso, L. (2008). Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/13727

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tasso, Leandro. “Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino.” 2008. Thesis, Universidade do Rio Grande do Sul. Accessed August 20, 2019. http://hdl.handle.net/10183/13727.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tasso, Leandro. “Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino.” 2008. Web. 20 Aug 2019.

Vancouver:

Tasso L. Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2008. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10183/13727.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tasso L. Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino. [Thesis]. Universidade do Rio Grande do Sul; 2008. Available from: http://hdl.handle.net/10183/13727

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Southern California

28. Park, Min-Hyung. Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5.

Degree: MS, Biomedical Engineering, 2006, University of Southern California

 Maximum likelihood estimation via the expectation maximization algorithm (EML) was implemented into ADAPT 5 to support population pharmacokinetic / pharmacodynamic studies. Two detailed simulation studies… (more)

Subjects/Keywords: population PK/PD; maximum likelihood; expectation maximization; IVGTT; minimal model; ADAPT

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Park, M. (2006). Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/26651/rec/5124

Chicago Manual of Style (16th Edition):

Park, Min-Hyung. “Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5.” 2006. Masters Thesis, University of Southern California. Accessed August 20, 2019. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/26651/rec/5124.

MLA Handbook (7th Edition):

Park, Min-Hyung. “Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5.” 2006. Web. 20 Aug 2019.

Vancouver:

Park M. Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5. [Internet] [Masters thesis]. University of Southern California; 2006. [cited 2019 Aug 20]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/26651/rec/5124.

Council of Science Editors:

Park M. Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5. [Masters Thesis]. University of Southern California; 2006. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/26651/rec/5124

29. Mulleman, Denis. Variabilité de réponse aux anti TNF-alpha dans les rhumatismes inflammatoires : apport des marqueurs biologiques et d'imagerie. : Variability of response to anti-TNF alpha in inflammatory rheumatisms : contribution of biological markers and imaging.

Degree: Docteur es, Sciences de la Vie et de la Santé, 2009, Université François-Rabelais de Tours

Il existe une variabilité interindividuelle de la relation dose - effet chez les patients atteints de maladies inflammatoires rhumatismales traités par les inhibiteurs du Tumor… (more)

Subjects/Keywords: Facteur de nécrose tumorale-alpha; Biomarqueurs; Biomédicaments; Relation dose-effet; Modélisation PK-PD; Tomographie par émission de Positons; Tumor necrosis factor-alpha

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mulleman, D. (2009). Variabilité de réponse aux anti TNF-alpha dans les rhumatismes inflammatoires : apport des marqueurs biologiques et d'imagerie. : Variability of response to anti-TNF alpha in inflammatory rheumatisms : contribution of biological markers and imaging. (Doctoral Dissertation). Université François-Rabelais de Tours. Retrieved from http://www.theses.fr/2009TOUR3113

Chicago Manual of Style (16th Edition):

Mulleman, Denis. “Variabilité de réponse aux anti TNF-alpha dans les rhumatismes inflammatoires : apport des marqueurs biologiques et d'imagerie. : Variability of response to anti-TNF alpha in inflammatory rheumatisms : contribution of biological markers and imaging.” 2009. Doctoral Dissertation, Université François-Rabelais de Tours. Accessed August 20, 2019. http://www.theses.fr/2009TOUR3113.

MLA Handbook (7th Edition):

Mulleman, Denis. “Variabilité de réponse aux anti TNF-alpha dans les rhumatismes inflammatoires : apport des marqueurs biologiques et d'imagerie. : Variability of response to anti-TNF alpha in inflammatory rheumatisms : contribution of biological markers and imaging.” 2009. Web. 20 Aug 2019.

Vancouver:

Mulleman D. Variabilité de réponse aux anti TNF-alpha dans les rhumatismes inflammatoires : apport des marqueurs biologiques et d'imagerie. : Variability of response to anti-TNF alpha in inflammatory rheumatisms : contribution of biological markers and imaging. [Internet] [Doctoral dissertation]. Université François-Rabelais de Tours; 2009. [cited 2019 Aug 20]. Available from: http://www.theses.fr/2009TOUR3113.

Council of Science Editors:

Mulleman D. Variabilité de réponse aux anti TNF-alpha dans les rhumatismes inflammatoires : apport des marqueurs biologiques et d'imagerie. : Variability of response to anti-TNF alpha in inflammatory rheumatisms : contribution of biological markers and imaging. [Doctoral Dissertation]. Université François-Rabelais de Tours; 2009. Available from: http://www.theses.fr/2009TOUR3113


Universidade do Rio Grande do Sul

30. Torres, Bruna Gaelzer Silva. Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa.

Degree: 2016, Universidade do Rio Grande do Sul

 Biofilmes são comunidades bacterianas complexas encapsuladas em matrizes poliméricas autoproduzidas e podem se desenvolver em superfícies inertes ou tecidos vivos. A formação do biofilme é… (more)

Subjects/Keywords: Biofilm-associated infections; Ciprofloxacino; Farmacocinética; P. aeruginosa; Farmacodinâmica; Ciprofloxacin; Infected lung microdialysis; Pseudomonas aeruginosa; PopPK modeling; Time-kill curves; Semi-mechanistic PK/PD modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Torres, B. G. S. (2016). Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/159488

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Torres, Bruna Gaelzer Silva. “Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa.” 2016. Thesis, Universidade do Rio Grande do Sul. Accessed August 20, 2019. http://hdl.handle.net/10183/159488.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Torres, Bruna Gaelzer Silva. “Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa.” 2016. Web. 20 Aug 2019.

Vancouver:

Torres BGS. Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2016. [cited 2019 Aug 20]. Available from: http://hdl.handle.net/10183/159488.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Torres BGS. Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa. [Thesis]. Universidade do Rio Grande do Sul; 2016. Available from: http://hdl.handle.net/10183/159488

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [30]

.